Cargando…
Fucoidan from Fucus vesiculosus suppresses hepatitis B virus replication by enhancing extracellular signal-regulated Kinase activation
BACKGROUND: Hepatitis B virus (HBV) infection is a serious public health problem leading to cirrhosis and hepatocellular carcinoma. As the clinical utility of current therapies is limited, the development of new therapeutic approaches for the prevention and treatment of HBV infection is imperative....
Autores principales: | Li, Huifang, Li, Junru, Tang, Yuan, Lin, Lin, Xie, Zhanglian, Zhou, Jia, Zhang, Liyun, Zhang, Xiaoyong, Zhao, Xiaoshan, Chen, Zhengliang, Zuo, Daming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603053/ https://www.ncbi.nlm.nih.gov/pubmed/28915824 http://dx.doi.org/10.1186/s12985-017-0848-8 |
Ejemplares similares
-
Fucoidan from Fucus vesiculosus Inhibits Inflammatory Response, Both In Vitro and In Vivo
por: Wang, Lingzhi, et al.
Publicado: (2023) -
Biological effects of fucoidan isolated from Fucus vesiculosus on thrombosis and vascular cells
por: Kwak, Kyu-Won, et al.
Publicado: (2010) -
Commercial Fucoidans from Fucus vesiculosus Can Be Grouped into Antiadipogenic and Adipogenic Agents
por: Oliveira, Ruth Medeiros, et al.
Publicado: (2018) -
Physicochemical and Biological Characterization of Fucoidan from Fucus vesiculosus Purified by Dye Affinity Chromatography
por: Zayed, Ahmed, et al.
Publicado: (2016) -
Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats
por: Pozharitskaya, Olga N., et al.
Publicado: (2018)